135 related articles for article (PubMed ID: 27317889)
1. Epidermal growth factor receptor signaling mediates aldosterone-induced profibrotic responses in kidney.
Sheng L; Yang M; Ding W; Zhang M; Niu J; Qiao Z; Gu Y
Exp Cell Res; 2016 Aug; 346(1):99-110. PubMed ID: 27317889
[TBL] [Abstract][Full Text] [Related]
2. A PPARgamma agonist inhibits aldosterone-induced mesangial cell proliferation by blocking ROS-dependent EGFR intracellular signaling.
Yuan Y; Zhang A; Huang S; Ding G; Chen R
Am J Physiol Renal Physiol; 2011 Feb; 300(2):F393-402. PubMed ID: 21123490
[TBL] [Abstract][Full Text] [Related]
3. Induction of renal fibrotic genes by TGF-β1 requires EGFR activation, p53 and reactive oxygen species.
Samarakoon R; Dobberfuhl AD; Cooley C; Overstreet JM; Patel S; Goldschmeding R; Meldrum KK; Higgins PJ
Cell Signal; 2013 Nov; 25(11):2198-209. PubMed ID: 23872073
[TBL] [Abstract][Full Text] [Related]
4. Aldosterone-induced mesangial cell proliferation is mediated by EGF receptor transactivation.
Huang S; Zhang A; Ding G; Chen R
Am J Physiol Renal Physiol; 2009 Jun; 296(6):F1323-33. PubMed ID: 19339632
[TBL] [Abstract][Full Text] [Related]
5. Aldosterone stimulates fibronectin synthesis in renal fibroblasts through mineralocorticoid receptor-dependent and independent mechanisms.
Chen D; Chen Z; Park C; Centrella M; McCarthy T; Chen L; Al-Omari A; Moeckel GW
Gene; 2013 Nov; 531(1):23-30. PubMed ID: 23994292
[TBL] [Abstract][Full Text] [Related]
6. Protein kinase D stabilizes aldosterone-induced ERK1/2 MAP kinase activation in M1 renal cortical collecting duct cells to promote cell proliferation.
McEneaney V; Dooley R; Harvey BJ; Thomas W
J Steroid Biochem Mol Biol; 2010 Jan; 118(1-2):18-28. PubMed ID: 19804826
[TBL] [Abstract][Full Text] [Related]
7. Urokinase-induced smooth muscle cell responses require distinct signaling pathways: a role for the epidermal growth factor receptor.
Nicholl SM; Roztocil E; Davies MG
J Vasc Surg; 2005 Apr; 41(4):672-81. PubMed ID: 15874933
[TBL] [Abstract][Full Text] [Related]
8. Novel Epidermal Growth Factor Receptor Inhibitor Attenuates Angiotensin II-Induced Kidney Fibrosis.
Qian Y; Peng K; Qiu C; Skibba M; Huang Y; Xu Z; Zhang Y; Hu J; Liang D; Zou C; Wang Y; Liang G
J Pharmacol Exp Ther; 2016 Jan; 356(1):32-42. PubMed ID: 26514795
[TBL] [Abstract][Full Text] [Related]
9. Andrographolide ameliorates diabetic nephropathy by attenuating hyperglycemia-mediated renal oxidative stress and inflammation via Akt/NF-κB pathway.
Ji X; Li C; Ou Y; Li N; Yuan K; Yang G; Chen X; Yang Z; Liu B; Cheung WW; Wang L; Huang R; Lan T
Mol Cell Endocrinol; 2016 Dec; 437():268-279. PubMed ID: 27378149
[TBL] [Abstract][Full Text] [Related]
10. Gefitinib attenuates transforming growth factor-β1-activated mitogen-activated protein kinases and mitogenesis in NRK-49F cells.
Chen SC; Guh JY; Lin TD; Chiou SJ; Hwang CC; Ko YM; Chuang LY
Transl Res; 2011 Oct; 158(4):214-24. PubMed ID: 21925118
[TBL] [Abstract][Full Text] [Related]
11. Prevention of renal vascular and glomerular fibrosis by epidermal growth factor receptor inhibition.
François H; Placier S; Flamant M; Tharaux PL; Chansel D; Dussaule JC; Chatziantoniou C
FASEB J; 2004 May; 18(7):926-8. PubMed ID: 15033924
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic targeting of aldosterone: a novel approach to the treatment of glomerular disease.
Brem AS; Gong R
Clin Sci (Lond); 2015 May; 128(9):527-35. PubMed ID: 25671776
[TBL] [Abstract][Full Text] [Related]
13. Erlotinib attenuates the progression of chronic kidney disease in rats with remnant kidney.
Yamamoto Y; Iyoda M; Tachibana S; Matsumoto K; Wada Y; Suzuki T; Iseri K; Saito T; Fukuda-Hihara K; Shibata T
Nephrol Dial Transplant; 2018 Apr; 33(4):598-606. PubMed ID: 28992288
[TBL] [Abstract][Full Text] [Related]
14. Antagonistic effects of bone morphogenetic protein-4 and -7 on renal mesangial cell proliferation induced by aldosterone through MAPK activation.
Otani H; Otsuka F; Inagaki K; Takeda M; Miyoshi T; Suzuki J; Mukai T; Ogura T; Makino H
Am J Physiol Renal Physiol; 2007 May; 292(5):F1513-25. PubMed ID: 17244894
[TBL] [Abstract][Full Text] [Related]
15. Aldosterone stimulates the cardiac Na(+)/H(+) exchanger via transactivation of the epidermal growth factor receptor.
De Giusti VC; Nolly MB; Yeves AM; Caldiz CI; Villa-Abrille MC; Chiappe de Cingolani GE; Ennis IL; Cingolani HE; Aiello EA
Hypertension; 2011 Nov; 58(5):912-9. PubMed ID: 22016493
[TBL] [Abstract][Full Text] [Related]
16. Connective tissue growth factor is a new ligand of epidermal growth factor receptor.
Rayego-Mateos S; Rodrigues-Díez R; Morgado-Pascual JL; Rodrigues Díez RR; Mas S; Lavoz C; Alique M; Pato J; Keri G; Ortiz A; Egido J; Ruiz-Ortega M
J Mol Cell Biol; 2013 Oct; 5(5):323-35. PubMed ID: 23929714
[TBL] [Abstract][Full Text] [Related]
17. Molecular mechanisms and therapeutic strategies of chronic renal injury: renoprotective effects of aldosterone blockade.
Nishiyama A; Abe Y
J Pharmacol Sci; 2006 Jan; 100(1):9-16. PubMed ID: 16397374
[TBL] [Abstract][Full Text] [Related]
18. Aldosterone induces myofibroblastic transdifferentiation and collagen gene expression through the Rho-kinase dependent signaling pathway in rat mesangial cells.
Diah S; Zhang GX; Nagai Y; Zhang W; Gang L; Kimura S; Hamid MR; Tamiya T; Nishiyama A; Hitomi H
Exp Cell Res; 2008 Dec; 314(20):3654-62. PubMed ID: 18929559
[TBL] [Abstract][Full Text] [Related]
19. Connective tissue growth factor induces renal fibrosis via epidermal growth factor receptor activation.
Rayego-Mateos S; Morgado-Pascual JL; Rodrigues-Diez RR; Rodrigues-Diez R; Falke LL; Mezzano S; Ortiz A; Egido J; Goldschmeding R; Ruiz-Ortega M
J Pathol; 2018 Feb; 244(2):227-241. PubMed ID: 29160908
[TBL] [Abstract][Full Text] [Related]
20. Insulin-like growth factor-I (IGF-I) induces epidermal growth factor receptor transactivation and cell proliferation through reactive oxygen species.
Meng D; Shi X; Jiang BH; Fang J
Free Radic Biol Med; 2007 Jun; 42(11):1651-60. PubMed ID: 17462533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
